Back to NTLA
VANGUARD GROUP INC NTLA Position History
Intellia Therapeutics, Inc. • Healthcare
Quarters held
21
Latest value
$6.5M
Q4 2025
Peak value
$177.4M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $75M |
| Q1 2025 | $151K |
| Q1 2025 | $272K |
| Q1 2025 | $721K |
| Q1 2025 | $302K |
| Q2 2025 | $100M |
| Q2 2025 | $199K |
| Q2 2025 | $359K |
| Q2 2025 | $831K |
| Q2 2025 | $403K |
| Q3 2025 | $740K |
| Q3 2025 | $177.4M |
| Q3 2025 | $366K |
| Q3 2025 | $17 |
| Q3 2025 | $1.2M |
| Q3 2025 | $11.1M |
| Q4 2025 | $109.2M |
| Q4 2025 | $219K |
| Q4 2025 | $420K |
| Q4 2025 | $608K |
| Q4 2025 | $6.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $6.5M | 725.5K | — | — |
| Q4 2025 | $608K | 67.7K | — | — |
| Q4 2025 | $420K | 46.7K | — | — |
| Q4 2025 | $219K | 24.3K | — | — |
| Q4 2025 | $109.2M | 12.15M | — | — |
| Q3 2025 | $11.1M | 642.7K | — | — |
| Q3 2025 | $1.2M | 67.7K | — | — |
| Q3 2025 | $17 | 1 | — | — |
| Q3 2025 | $366K | 21.2K | — | — |
| Q3 2025 | $177.4M | 10.27M | — | — |
| Q3 2025 | $740K | 42.9K | — | — |
| Q2 2025 | $403K | 43.0K | — | — |
| Q2 2025 | $831K | 88.6K | — | — |
| Q2 2025 | $359K | 38.3K | — | — |
| Q2 2025 | $199K | 21.2K | — | — |
| Q2 2025 | $100M | 10.66M | — | — |
| Q1 2025 | $302K | 42.5K | — | — |
| Q1 2025 | $721K | 101.4K | — | — |
| Q1 2025 | $272K | 38.2K | — | — |
| Q1 2025 | $151K | 21.2K | — | — |
| Q1 2025 | $75M | 10.55M | — | — |